Bioconjugated liquid-like solid enhances characterization of solid tumor - chimeric antigen receptor T cell...

Area of Science:

• Immunotherapy
• Oncology
• Cellular Biology

Background:

• Chimeric antigen receptor (CAR) T cell therapy is highly effective against blood cancers but faces challenges in solid tumors due to limited T cell trafficking and infiltration within the tumor microenvironment (TME).
• Current preclinical models often fail to accurately replicate the complex interactions between CAR T cells and the solid tumor microenvironment, hindering the evaluation of CAR T cell efficacy.
• Understanding the mechanisms governing CAR T cell function in solid tumors is crucial for advancing this immunotherapy approach.

Purpose of the Study:

• To investigate the immune trafficking and anti-tumor activity of CD70-specific CAR T cells within a novel 3D microchannel network simulating the solid tumor microenvironment.
• To elucidate the role of chemotaxis and effector-to-target ratios in CAR T cell-mediated anti-tumor responses against solid tumors.
• To analyze gene expression profiles of immune subpopulations involved in CAR T cell therapy for solid tumors.

Main Methods:

• Development and utilization of a bio-conjugated liquid-like solid (LLS) medium with a confined 3D microchannel network to model the solid tumor microenvironment.
• Evaluation of CD70-specific CAR T cell migration, infiltration, and anti-tumor activity against CD70-expressing glioblastoma and osteosarcoma models.
• Comprehensive analysis of cytokine and chemokine profiles, in situ imaging, and single-cell transcriptomic profiling.

Main Results:

• Demonstrated successful migration and infiltration of CAR T cells within the 3D microchannel network, leading to significant anti-tumor activity against glioblastoma and osteosarcoma models.
• Identified chemotaxis as a primary mechanism for immune cell recruitment and highlighted the critical role of the effector-to-target ratio in CAR T cell efficacy.
• Revealed differential gene expression patterns among immune subpopulations through single-cell transcriptomic analysis, providing insights into cellular responses.

Conclusions:

• The developed 3D in vitro model effectively simulates the solid tumor microenvironment, enabling detailed study of CAR T cell dynamics and interactions.
• CAR T cell therapy holds potential for solid tumors, with migration, chemotaxis, and effector-to-target ratios being critical determinants of therapeutic success.
• These findings offer valuable insights for optimizing CAR T cell strategies and developing future immunotherapies for solid tumors.